 1. Anti-cancer chemotherapy, radiotherapy, immunotherapy, or investigational agents within 7 days of first dose provided all treatment-related adverse events have resolved or have been deemed irreversible, with the exception for a single dose radiation up to 8 Gray equal to 800 RAD with palliative intent for pain control up to 7 days before beginning the administration of BBI608. 